Johnson & Johnson is offering to pay $8.9 billion to settle talc cancer claims.
Johnson & Johnson is offering to pay $8.9 billion to settle talc cancer claims.
J&J subsidiary LTL filed for bankruptcy to resolve cosmetic talc litigation.
J&J subsidiary LTL filed for bankruptcy to resolve cosmetic talc litigation.
J&J subsidiary LTL filed for bankruptcy to resolve cosmetic talc litigation.
J&J subsidiary LTL filed for bankruptcy to resolve cosmetic talc litigation.
J&J's LTL spinoff increased settlement offer by $6.9 billion, securing commitments from 60,000 claimants.
J&J's LTL spinoff increased settlement offer by $6.9 billion, securing commitments from 60,000 claimants.
J&J has long held that talcum powder products are safe, but juries have awarded some customers billions of dollars in damages.
J&J has long held that talcum powder products are safe, but juries have awarded some customers billions of dollars in damages.
Johnson & Johnson believes the claims are specious and lack scientific merit, but resolving them in the tort system would take decades and impose significant costs.
Johnson & Johnson believes the claims are specious and lack scientific merit, but resolving them in the tort system would take decades and impose significant costs.
J&J's bankruptcy benefits both claimants and company by getting money to claimants faster and ending litigation.
J&J's bankruptcy benefits both claimants and company by getting money to claimants faster and ending litigation.
Medical costs can range from $140,000 to $1.4 million for ovarian cancer and mesothelioma.
Medical costs can range from $140,000 to $1.4 million for ovarian cancer and mesothelioma.
Medical costs can range from $140,000 to $1.4 million for ovarian cancer and mesothelioma.
Medical costs can range from $140,000 to $1.4 million for ovarian cancer and mesothelioma.